Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients

NCT00080106 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

114

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: MRK Ad5 HIV-1 gag vaccine
OTHER: Vaccine placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)